Phase 2 Trial of a Novel COPD Treatment
- Author
- American Thoracic Society
- Published
- Fri 01 May 2015
- Episode Link
- https://share.transistor.fm/s/6149b4fe
Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.
